Published in Nutr Cancer on June 04, 2014
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Prevalence and trends in obesity among US adults, 1999-2008. JAMA (2010) 50.58
Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol (1989) 7.47
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Diabetes and cancer: a consensus report. CA Cancer J Clin (2010) 3.95
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol (2013) 3.72
Cachexia in cancer patients. Nat Rev Cancer (2002) 3.63
Regulation of lipolysis in adipocytes. Annu Rev Nutr (2007) 3.15
The medical complications of obesity. QJM (2006) 2.93
Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol (2012) 2.45
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle (2010) 2.04
Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol (1986) 2.01
The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract (2005) 1.55
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol (2011) 1.41
Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma. Int J Cancer (1995) 1.06
Nutrition and cancer: physiological interrelationships. Annu Rev Nutr (1985) 0.99
Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med (2011) 0.94
Ubiquitin-proteasome-dependent proteolysis in skeletal muscle. Reprod Nutr Dev (1998) 0.90
Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey. Cancer Causes Control (2010) 0.90
'The reflections you get': an exploration of body image and cachexia. Int J Palliat Nurs (2007) 0.86
Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis. Life Sci (2011) 0.84
Characterization of the Yoshida sarcoma: a model of cancer cachexia. Support Care Cancer (2013) 0.82
Relationship between tumor growth and cachexia during progressive malignant disease: a new measure of the extent of cachexia, the cachexia index. Anticancer Res (1991) 0.78
Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol (2004) 1.74
Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol (2004) 1.64
Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci U S A (2007) 1.61
The role of insulin resistance in the development of muscle wasting during cancer cachexia. J Cachexia Sarcopenia Muscle (2011) 1.00
Characterization of the Yoshida sarcoma: a model of cancer cachexia. Support Care Cancer (2013) 0.82
Effects of consuming a high carbohydrate diet after eight weeks of exposure to a ketogenic diet. Nutr Metab (Lond) (2009) 0.82
Repeated gastric distension alters food intake and neuroendocrine profiles in rats. Physiol Behav (2011) 0.81
Glucose tolerance in response to a high-fat diet is improved by a high-protein diet. Obesity (Silver Spring) (2011) 0.79
Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma. Horm Cancer (2013) 0.75